Kieran Daly discusses how adherence programs can improve patient outcomes, support specialty pharmacy performance, and reduce healthcare costs. Tracking when a prescription ships or a refill is ...

Formulary exclusions have expanded from ~30 to ~1,400 in a decade, reflecting insurer responses to crowded classes and accelerating the migration of certain brands toward cash channels. Retail step ...

Payers and providers now expect RWE to complement trial efficacy by demonstrating effectiveness, utilization impact, and ROI ...

Claude Code is expected to standardize and accelerate software and AI development while improving access to data and ...

In this week's Pharma Pulse, the Trump administration expands TrumpRx to over 600 generics, the Supreme Court clears the way for long-term Medicare drug price negotiations, Eli Lilly moves deeper into ...

National polling indicates 54% of rural adults face at least one healthcare access barrier, underscoring that “access” is multidimensional and differs from coverage-centric system design. High cost ...

Rahul Mittal explains how execution infrastructure can help generics manufacturers improve hospital access, reduce delays, and strengthen coordination. The US hospital generics market continues to ...

Execution infrastructure converts early commercial and supply signals into owned, cross-functional workflows with decision logic and closure tracking, preventing insights from stalling in dashboards.

Formulary positioning and benefit design frequently determine utilization, as weak placement or reimbursement dynamics can ...

TrumpRx’s sevenfold formulary expansion positions a government-backed portal as a high-volume generics price aggregator rather than a dispensing pharmacy. Tariff exemptions tied to three-year ...